Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31, 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon